OOIR: Observatory of International Research

Papers

(The H4-Index of International Journal of Cancer is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Issue Information	621
Issue Information	245
	208
	113
Issue Information	108
Latent class analysis‐derived classification improves the cancer‐specific death stratification of lymphomas: A large retrospective cohort study	101
Issue Information	89
Mammographic breast density, body mass index and risk of breast cancer in Korean women aged 75 years and older	88
Assessment of long‐term survival in childhood cancer patients using cancer registry data from eastern China: Period analysis outperforms traditional analysis	74
A comprehensive investigation of histotype‐specific microRNA and their variants in Stage I epithelial ovarian cancers	71
Issue Information	70
	68
Comments on “Methylation scores for smoking, alcohol consumption and body mass index and risk of seven types of cancer”	63
Improving colon cancer screening in Poland. In search of the Holy Grail	61
Pre‐diagnostic circulating resistin concentrations and mortality among individuals with colorectal cancer: Results from the European Prospective Investigation into Cancer and Nutrition study	60
Dipeptidyl peptidase‐4 in the tumor microenvironment of the digestive system: Molecular mechanisms and therapeutic targets	60
Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population‐based cohort study	60
Urokinase Plasminogen Activator Receptor‐Associated Protein ( uPARAP ) as a Potential Next Generation Molecular Target for Treatment of Gastrointesti	58
Trends in cancer incidence by socioeconomic deprivation in Germany in 2007 to 2018: An ecological registry‐based study	58
Pan‐cancer analysis reveals molecular signatures for predicting matrix stiffness in solid tumors	58
Body mass index and body shape before treatment and nasopharyngeal carcinoma prognosis: A population‐based patient cohort study in southern China	57
Cervical cancer screening: Sharing best practices and addressing common challenges in cervical cancer screening programs	56
Erratum	56
Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer	55
Gynaecologic and breast cancers in women living with HIV in South Africa: A record linkage study	54

Longitudinal changes in health‐related quality of life after a breast cancer diagnosis in sub‐Saharan Africa: Evidence from the prospective ABC ‐	54
The current status of cell‐free human papillomavirus DNA as a biomarker in cervical cancer and other HPV‐associated tumors: A review	51
Development and psychometric properties of a general cancer stigma scale	50
The cervico‐vaginal DNA methylation WID ‐ qEC t	49
The landscape of genetic aberrations in myxofibrosarcoma	48
Identification of pre‐diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis: A nested case‐control study within the ATBC cohort	48
Education level and risk of breast cancer by tumor subtype in the EPIC cohort	47
Polymorphisms within autophagy‐related genes as susceptibility biomarkers for pancreatic cancer: A meta‐analysis of three large European cohorts and functional characterization	46
Delivered relative dose intensity in adolescent and young adult germ cell tumours in England: Assessment of data quality and consistency from clinical trials compared to national cancer registration d	46
Maternal illnesses during pregnancy and the risk of childhood cancer: A medical‐record based analysis (UKCCS)	45
Mediation effect of intestinal microbiota on the relationship between fiber intake and colorectal cancer	44
Physical activity and mortality in melanoma patients within the Norwegian Women and Cancer study (NOWAC)	44
Issue Information	42
Antiviral prophylaxis for hepatitis B virus reactivation in T‐cell lymphoma patients with resolved hepatitis B virus infection	42
Cost‐effectiveness of risk‐stratified screening for cervical cancer in cohorts vaccinated against human papillomavirus with moderate vaccination coverage	42
Clinical validation of a DNA methylation biomarker associated with overall survival of relapsed ovarian cancer patients	41
Survival rates and extra‐regional migration patterns of children and adolescents with cancer in Italy: The 30‐year experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP) wi	41